Verdad Advisers »

Cytomx Therapeutics shares owned by Verdad Advisers

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Verdad Advisers from 13F filings

Historical chart of Verdad Advisers investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Verdad Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Verdad Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $142k 30k 4.70

More positions owned by Verdad Advisers

Belite Bio Sponsored Ads (BLTE)
State Street Corporation (STT)
Autohome Sp Ads Rp Cl A (ATHM)
Revolution Medicines (RVMD)
Zymeworks Del (ZYME)
Cal Maine Foods Com New (CALM)
Zoom Communications Cl A (ZM)
California Res Corp Com Stock (CRC)
Tenax Therapeutics Com New (TENX)
ACADIA Pharmaceuticals (ACAD)
Par Pac Holdings Com New (PARR)
Johnson & Johnson (JNJ)
Micron Technology (MU)
Nurix Therapeutics (NRIX)
Comcast Corp Cl A (CMCSA)

View all positions for Verdad Advisers

Top funds holding Cytomx Therapeutics

FMR
Kynam Capital Management
Bank of America Corporation
Perceptive Advisors
VR Adviser
Vanguard Capital Management
Point72 Asset Management
Citadel Advisors
State Street Corporation
BlackRock
Baker Bros. Advisors
Elmind Capital
Nextech Invest
Marshall Wace
Millennium Management

View all funds holding Cytomx Therapeutics